Neela Cell Therapeutics
PrivateLast Round
Convertible Debt
Nov 24, 2025
Total Funding Raised
$13.56M
Company Overview
Neela Cell Therapeutics is a biotechnology company developing genipin as a treatment for peripheral neuropathy and producing peripheral neurons from human pluripotent stem cells for research.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neela Cell Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Neela Cell Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Nov 24, 2025 | ||||
| Grant | Jun 1, 2025 |
Neela Cell Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Georgia Research Alliance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 24, 2025
$14M round led by Biogen.
- Jun 1, 2025
$50K grant received from Georgia Research Alliance.
Neela Cell Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neela Cell Therapeutics's valuation, stock price, and market status.
Firmographic Details
HeadquartersAthens, Georgia
Year Founded2024
Last FundingNov 24, 2025
